Parathyroid Hormone
Research News and Information

Sunday, November 22, 2009

Rapamycin impairs trabecular bone acquisition from high-dose but not low-dose intermittent parathyroid hormone treatment.

29 Nov 2009 The osteo-anabolic effects of intermittent parathyroid hormone (PTH) treatment require insulin-like growth factor (IGF) signaling through the IGF-I receptor. A major downstream target of the IGF-I receptor (via Akt) is the mammalian target of ... Read more...

Lessons from thymic epithelial heterogeneity: FoxN1 and tissue-restricted gene expression by extrathymic, endodermally derived epithelium.

26 Sep 2009 Modeling of thymic epithelial differentiation has been guided by several important underlying assumptions. One is that within epithelial tissues derived from pharyngeal endoderm, FoxN1 expression is signature for the thymic epithelial lineage. ... Read more...

The influence of chronic renal failure on drug metabolism and transport.

21 Sep 2009 Chronic renal failure (CRF) has been shown, in animal models and clinical studies, to significantly reduce nonrenal clearance and to alter the bioavailability of predominantly metabolized drugs. Phase II reactions and drug transporters such as ... Read more...

Latest indexed articles for 'Parathyroid Hormone'

These are the very latest articles for this heading:

• Rapamycin impairs trabecular bone acquisition from high-dose but not low-dose intermittent parathyroid hormone treatment. 29 Nov 2009
• When two keys fit one lock, surprises follow. 29 Sep 2009
• Lessons from thymic epithelial heterogeneity: FoxN1 and tissue-restricted gene expression by extrathymic, endodermally derived epithelium. 26 Sep 2009
• The influence of chronic renal failure on drug metabolism and transport. 21 Sep 2009
• Hyperparathyroidism and vitamin D deficiency predispose to bone loss in renal transplant recipients. 13 Sep 2009
• [Emergencies in hematology and oncology] 8 Sep 2009
• Vitamin D levels in healthy men in eastern Saudi Arabia. 30 Aug 2009
• Short-term effects of parathyroid hormone on rat lumbar vertebrae. 30 Aug 2009
• Parathyroid FNA and hormone assay. 30 Aug 2009
• Vitamin D. Bone benefits and beyond. 30 Aug 2009
• Role of vitamin D deficiency in continued hyperparathyroidism following parathyroidectomy. 30 Aug 2009
• Bone mineral density, osteocalcin, and bone-specific alkaline phosphatase in patients with insulin-dependent diabetes mellitus. 30 Aug 2009
• Changes of bone formation markers osteocalcin and bone-specific alkaline phosphatase in postmenopausal women with osteoporosis. 30 Aug 2009
• Re-operative parathyroidectomy: an algorithm for imaging and monitoring of intraoperative parathyroid hormone levels that results in a successful focused approach. 30 Aug 2009
• Commentary. 30 Aug 2009
• Commentary. 30 Aug 2009
• A case of renal osteodystrophy with unexpected serum intact parathyroid hormone concentrations. 30 Aug 2009
• Distinctive anabolic roles of 1,25-dihydroxyvitamin D(3) and parathyroid hormone in teeth and mandible versus long bones. 25 Aug 2009
• Sustained cyclic AMP production by parathyroid hormone receptor endocytosis. 21 Aug 2009
• Deletion of the vitamin D receptor specifically in the parathyroid demonstrates a limited role for the receptor in parathyroid physiology. 17 Aug 2009

See a longer list of these articles.

Technical information about 'Parathyroid Hormone'

Definition: A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates.

Registry Number: 0

Descriptor UI: D010281

Alternative terms: Parathyroid Hormone; Hormone, Parathyroid; PTH (1-84); Parathyroid Hormone (1-84); Parathormone; Parathyrin; Parathyroid Hormone Peptide (1-34); PTH(1-34); Parathyroid Hormone (1-34);

Related Mesh Headings: Hypoparathyroidism; Parathyroid Hormone-Related Protein;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D06.472.699.590; D12.644.548.587;

History Note: 2004(1963-1981); for PARATHYROID HORMONE PEPTIDE (1-34) use TERIPARATIDE 1997-2007

Technical Notes: /defic: consider also HYPOPARATHYROIDISM